🔴 Immix Biopharma is trading 5.26% down today with no clear catalyst identified

Immix Biopharma is trading 5.26% lower at $11.09 after no clear company-specific announcement was identified for September 25, 2026.

• Recent coverage also reported no new macro, sector, or company-specific catalyst.
• The decline follows losses on September 23 and September 24, while broader markets are mixed rather than sharply weaker.
• Elevated Treasury yields and crude prices remain relevant background pressures, but available evidence does not establish a definitive cause.